The new test focuses on mutations in the NPM1 and FLT3 genes, which are among the most common causes of leukemia in younger ...

RFK Jr. wants placebo trials for vaccines. A Northwestern researcher says that's unethical.

Cancer 360 brings patient data into one central system, so clinicians can prioritise those most in need and see patients quicker Millions of patients ...

Last time there was no status LED included in the design, and the recessed reset switch and micro-USB power input were on ...

Q1 2025 Earnings Call Transcript May 1, 2025 X4 Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $4.0E-5, ...

Regulus Therapeutics will be acquired by Novartis AG for $7 per share in cash. Click here for more information on RGLS ...

While chemotherapy, radiation and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some ...

The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

On the call from BioMarin management today are Alexander Hardy, President and Chief Executive Officer; Brian Mueller, Executive Vice President, Chief Financial Officer; Cristin Hubbard, Executive Vice ...

Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among ...

Zevaskyn won FDA approval upon Abeona’s second filing of a biologics license application (BLA) for the therapy.

The U.S. Food and Drug Administration (FDA) approved Kamada's application to manufacture CYTOGAM in May 2023. During the year ...